Saving changes...

Done

Error

2018 ACCP Journal of Clinical Pharmacology Journal CE January | Thyroxin Use Is Associated With Increased Risk of Thyroid Cancer in Patients With Hypothyroidism

2018 ACCP Journal of Clinical Pharmacology Journal CE January | Thyroxin Use Is Associated With Increased Risk of Thyroid Cancer in Patients With Hypothyroidism

2018 ACCP Journal of Clinical Pharmacology Journal CE January | Thyroxin Use Is Associated With Increased Risk of Thyroid Cancer in Patients With Hypothyroidism

Shih-Han Hung,MD, Shiu-Dong Chung,MDPhD, and Herng-Ching Lin, PhD
Shih-Han Hung,MD, Shiu-Dong Chung,MDPhD, and Herng-Ching Lin, PhD
on behalf of American College of Clinical Pharmacology

$10.00 $ 10.00 $ 10.00

$ 10.00 $ 10.00 $ 10.00
$ 10.00 $ 10.00 $ 10.00
Normal Price: $10.00 $10.00

Review:

Launch date: 05 Jun 2018
Expiry Date: 01 Jan 2021

Last updated: 26 Dec 2019

Reference: 189570

This course is no longer available

Exam is embedded in the course
No preview available
No Exam Available

Latest User Comments

I would like to...

Course Availability

This course is only available to trainees days after purchase. It would need to be repurchased by the trainee if not completed in the allotted time period. This course is no longer available. You will need to repurchase if you wish to take the course again.

You have null days left.

Description

This research study provides an analysis of the relationship between thyroxin use and carcinogenesis using data available from a National Health System database. The study’s results assist clinicians and pharmacists in evaluating the risk and benefits of thyroid replacement therapy in subclinical hypothyroidism. A novel finding, the study provides discussion of research limitations and implications for future research.

Objectives

Objective 1:
Differentiate between the study group classifications of regular and irregular thyroxin use.
Objective 2:
List 4 statistically significant co-morbidities found amongst thyroid cancer patients versus the controls.
Objective 3:
Discuss two possible explanations for thyroxin-related carcinogenesis.
Objective 4:
Describe the study's implications when evaluating treatment options for patients with subclinical hypothyroidism.
Shih-Han Hung,MD, Shiu-Dong Chung,MDPhD, and Herng-Ching Lin, PhD

Author Information Play Video Bio

Shih-Han Hung,MD, Shiu-Dong Chung,MDPhD, and Herng-Ching Lin, PhD
on behalf of American College of Clinical Pharmacology

In the 1960s, a group of eminent physicians formulated the concept of an organization dedicated to a new branch of pharmacology that dealt with the effectiveness and safety of drugs in man. As a result of their efforts, the American College of Clinical Pharmacology (ACCP) was founded on September 11, 1969. Today, ACCP consists of a full spectrum of clinical pharmacology professionals from academia, industry, government and clinical settings who span the scope from research and drug development to patient-related care and who remain dedicated to advancing clinical pharmacology with the ultimate goal of enhancing patient care.

As an organization whose primary role is education, ACCP does not concentrate on any one aspect of the discipline. Rather, it seeks to address the educational needs of its diverse membership and all healthcare professionals, covering a range of topics that span the entire area of the interaction between drugs and humans. These areas include, but are not limited to, pharmaceutical chemistry, biochemistry, drug metabolism, pharmacokinetics, pharmacodynamics, pharmacometrics, pharmacogenomics clinical pharmacology practice in the outpatient and inpatient settings, human toxicology, drug interactions and clinical drug trials. The diversity of ACCP is expressed not only in the composition of its membership, but also in its leadership. Maintaining a balance of elected Regents and Officers from all pertinent professional backgrounds ensures that ACCP remains attuned to the needs of all professionals engaged in the practice of or with a strong interest in clinical pharmacology, from the research laboratory (academic and industrial) to the classroom, and from clinical trials to improved patient care.

Current Accreditations

This course has been certified by or provided by the following Certified Organization/s:

  • Accreditation Council for Continuing Medical Education (ACCME)
  • 1.00 Credits
  • Accreditation Council for Pharmacy Education (ACPE)
  • 1.00 Hours -
    Exam Pass Rate: 75

Faculty and Disclosures

Additional Contributors

Conflicts Declared

Conflicts of Interest declaration by Author:

null

User Reviews (0)

Go Back

Loading...


Saving changes...

Done

Error